新闻
基立福最新新闻资源。您可以按年份和新闻类别搜索所有已发布的新闻稿，或使用下面的搜索栏进行搜索。
显示206项搜索结果
Grifols announces topline phase 3 data on long-term Albutein® (albumin [human] U.S.P.) therapy for decompensated cirrhosis with ascites
Grifols ranked number one biotech company in Dow Jones Sustainability Indices
Grifols concludes balance sheet improvement process with private placement of Senior Secured Notes and Revolving Credit Facility extension
Grifols’ Board of Directors Announces Termination of Acquisition Discussions with Brookfield
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Grifols Delivers Strong Third-Quarter Performance Led by Biopharma 12.1% Growth
Grifols awarded Gold Medal by EcoVadis for Sustainability Excellence
Grifols receives FDA approval to treat surgical bleeding in pediatric patients with its fibrin sealant solution
Grifols receives SBTi approval for its near-term science-based emission reduction targets
Grifols partners with BARDA for proof-of-concept testing of ocular immunoglobulin as treatment for sulfur mustard-induced eye injury
Grifols achieves its highest-ever score in the 2024 S&P Global Sustainability Assessment
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat